looking to see if a particular lipid and protein mixture currently used to help improve lung function in premature babies can be used in the fight against the novel coronavirus.Lawson researchers are hoping to determine if bovine lipid extract surfactant suspension (BLES®) — which is manufactured in London, Ont., and does not have any generic counterparts — can be used to treat respiratory failure resulting from COVID-19.
London, Ont., researchers the first to profile immune response to COVID-19 “We’ve actually done some research at the Lawson for over 30 years now, looking at a substance called surfactant,” Dr.
Jim Lewis, Lawson scientist and respirologist at St. Joseph’s Health Care London, said on The Craig Needles Show.“Now, for most.